K-numberK243513
Device nameDCM (PW-DCM)
ApplicantPneumowave, Ltd.
Product codeLEL
Device classClass II
Decision dateApr 16, 2025
DecisionSubstantially Equivalent
Regulation882.5050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The DCM (PW-DCM) is a wrist-worn activity monitor that continuously records physical movement data using a triaxial accelerometer. It is designed for physiological monitoring applications including sleep activity tracking, circadian rhythm analysis, and general quantifiable motion assessment in adult patients only. The device transmits data via a mobile app to a cloud platform where healthcare professionals access results through a web-based dashboard.

Technological characteristics

The DCM uses a triaxial MEMS accelerometer with 0.061 mg/LSB sensitivity and ±2g dynamic range operating at 12.5 Hz, powered by a lithium coin-cell battery. The biosensor mounts on an EKG electrode or wrist strap and communicates wirelessly to an off-the-shelf mobile device running the DCM app, which relays data to cloud storage. The predicate Actigraph LEAP also uses triaxial MEMS acceleration measurement in 3 axes, mounted on wrist-worn hardware, though with different technical specifications (3 mg/LSB sensitivity, ±8g range, 32-256 Hz frequency).

Test standards cited

Testing included IEC 62366-1 (usability), IEC 60601-1-2 (EMC), 47 CFR Part 15 Subpart B (electromagnetic emissions), ANSI C63.27 (wireless coexistence), 47 CFR 15.247 (spurious emissions), IEC 60601-1 and IEC 60601-1-11 (electrical safety), and IEC 62304 (software development lifecycle).

Substantial equivalence argument

Both devices measure linear acceleration in 3 axes to quantify physical movement in wrist-worn form for adult patients using continuous retrospective monitoring. They share identical indications for use (physiological monitoring, sleep activity, circadian rhythm analysis) and prescription classification. Although the DCM has different technical specifications (lower sensitivity, narrower range, lower frequency), these represent equivalent performance ranges suitable for the same intended purpose. Both employ triaxial MEMS accelerometry, non-sterile delivery, and lack respiratory rate measurement, apnea claims, or patient alarms—establishing technological equivalence despite implementation differences.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →